Evert Austin Eriksson

Dr. Evert Austin Eriksson

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Journal of Critical Care
Verified
Journal Article
Closed access
ADAndrew R. Doben
Andrew R. Doben
EEEvert Austin Eriksson
Evert Austin Eriksson
CDChadrick E. Denlinger
Chadrick E. Denlinger
SLStuart M. Leon
Stuart M. Leon
DCDeborah J. Couillard
Deborah J. Couillard
CMChristian T. Minshall
Christian T. Minshall

1 August 2011 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
EEEvert Austin Eriksson
Evert Austin Eriksson
DPDaniela C. Bsn Pellegrini
Daniela C. Bsn Pellegrini
WVWayne E. Vanderkolk
Wayne E. Vanderkolk
CMChristian T. Minshall
Christian T. Minshall
SFSamir M. Fakhry
Samir M. Fakhry
SCStephen D. Cohle
Stephen D. Cohle
Background: To determine the incidence, time course, and severity of pulmonary fat embolism (PFE) and cerebral fat embolism (CFE) in trauma and nontrauma patients at the time of autopsy. Methods: Prospectively, consecutive patients presenting for autopsy were evaluated for evidence pulmonary and brain fat embolism. The lung sections were obtained from the upper and lower lobe of the patients' lungs on the right and left and brain tissue. This tissue was prepared with osmium tetroxide for histologic evaluation. The number of fat droplets per high power field was counted for all sections. The autopsy reports and medical records were used to determine cause of death, time to death, injuries, if cardiopulmonary resuscitation (CPR) was attempted, sex, height, weight, and age. Results: Fifty decedents were evaluated for PFE and CFE. The average age was 45.8 years ± 17.4 years, average body mass index was 30.1 kg/cm2 ± 7.0 kg/cm2, and 68% of the patients were men. The cause of death was determined to be trauma in 68% (34/50) of decedents, with 88% (30/34) blunt and 12% (4/34) penetrating. CPR was performed on 30% (15/50), and PFE was present in 76% (38/50) of all patients. Subjects with PFE had no difference with respect to sex, trauma, mechanism of injury, CPR, external contusions, fractures, head, spine, chest, abdominal, pelvic, and extremity injuries. However, subjects without PFE had significantly increased weight (109 ± 29 kg vs. 86 ± 18 kg; p = 0.023) but no difference in height or body mass index. PFE was present in 82% (28/34) of trauma patents and 63% (10/16) nontrauma patients. Eighty-eight percent of nontrauma patients and 86% of trauma patients who received CPR had PFE. Trauma patients with PFE showed no significant difference in any group. Eighty-eight percent of trauma patients died within 1 hour of injury, and 80% (24/30) of them had PFE at the time of autopsy. CFE was present only in one patient with a severe head and cervical spine injury. Conclusion: PFE is common in trauma patients. CPR is associated with a high incidence of PFE regardless of cause of death. PFE occurs acutely within the “golden hour” and should be considered in traumatically injured patients. Further studies are needed to evaluate the pathogenesis of PFE.

1 June 2012 in Clinical Neurophysiology
Verified
Journal Article
Closed access
EEEvert Austin Eriksson
Evert Austin Eriksson
JBJeffrey F Barletta
Jeffrey F Barletta
BFBryan E. Figueroa
Bryan E. Figueroa
BBBruce W. Bonnell
Bruce W. Bonnell
WVWayne E. Vanderkolk
Wayne E. Vanderkolk
MOMickey M. Ott
Mickey M. Ott

1 August 2011 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
CMChristian T. Minshall
Christian T. Minshall
EEEvert Austin Eriksson
Evert Austin Eriksson
SLStuart M. Leon
Stuart M. Leon
ADAndrew R. Doben
Andrew R. Doben
BMBrian P. McKinzie
Brian P. McKinzie
SFSamir M. Fakhry
Samir M. Fakhry
Timing and type of chemoprophylaxis (CP) that should be used in patients with traumatic brain injury (TBI) remains unclear. We reviewed our institutions experience with low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH) in TBI. The charts of all TBI patients with a head abbreviated injury severity score >2 (HAIS) and an intensive care unit length of stay >48 hours admitted during a 42-month period between 2006 and 2009 were reviewed. CP was initiated after intracranial hemorrhage was considered stable. We reviewed all operative notes and radiologic reports in these patients to analyze the rate of significant intracranial hemorrhagic complications, deep venous thrombosis, or pulmonary embolus. A total of 386 patients with TBI were identified; 158 were treated with LMWH and 171 were treated with UFH. HAIS was significantly different between the LMWH (3.8 ± 0.7) and UFH (4.1 ± 0.7) groups; the time to initiation of CP was not. The UFH group had a significantly higher rate of deep venous thrombosis and pulmonary embolus. Progression of ICH that occurred after the initiation of CP was significantly higher in the UFH-treated patients (59%) when compared with those treated with LMWH (40%). Two patients in the UFH group required craniotomy after the initiation of CP. LMWH is an effective method of CP in patients with TBI, providing a lower rate of venous thromboembolic and hemorrhagic complications when compared with UFH. A large, prospective, randomized study would better evaluate the safety and efficacy of LMWH in patients suffering blunt traumatic brain injury.

1 April 2021 in Surgery
Verified
Journal Article
Closed access
MNMiriam Y. Neufeld
Miriam Y. Neufeld
WBWayne Bauerle
Wayne Bauerle
EEEvert Austin Eriksson
Evert Austin Eriksson
FAFaris K. Azar
Faris K. Azar
HEHeather L. Evans
Heather L. Evans
FDF. Thurston Drake
F. Thurston Drake

1 March 2010 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
MOMickey Meilinger Ott
Mickey Meilinger Ott
EEEvert Austin Eriksson
Evert Austin Eriksson
WVWayne Vanderkolk
Wayne Vanderkolk
DCDavid Christianson
David Christianson
ADAlan Davis
Alan Davis
DSDonald Scholten
Donald Scholten
Background: As the population continues to age, the number of patients undergoing traumatic injury while on antiplatelet or anticoagulation therapies is increasing. Mortality has been shown to increase in traumatic brain injury patients on warfarin therapy. Whether this increased mortality is seen in trauma patients without traumatic brain injury remains controversial. We investigated whether patients on antiplatelet and/or anticoagulation therapy were at increased risk of death from blunt traumatic injury in the absence of head injury. Methods: A retrospective review of our Level I trauma center database was performed from 2002 to 2007. Inclusion criteria included all patients older than 60 years admitted to the trauma service. Only patients with a computed tomography scan negative for intracranial injury were analyzed. Results: Two hundred twelve patients were found, of which 67 were found to be taking aspirin, warfarin, clopidogrel, or a combination of the three. Injury Severity Score (21 vs. 21), length of stay (11 days vs. 9 days), intensive care unit days (5 days vs. 4 days), and deaths (13% vs. 10%) were similar between those patients on antiplatelet/anticoagulation therapy and those who were not. Conclusion: In the absence of traumatic brain injury, the use of preinjury antiplatelet and/or anticoagulation therapy does not significantly increase the risk of mortality in the trauma patient. As the number of active seniors rises, this patient population will continue to present to the trauma service. To the best of our knowledge, this study is one of the largest addressing this question, and the only study examining the addition of antiplatelet therapy.